Therapies targeting MTFP1 may enhance the sensitivity of cancer cells to treatment by restoring mitochondrial function (maintain cellular energy production, regulate apoptosis, and balance cellular stress responses) and decreasing the activity of glycolytic metabolism (Rolver et al., 2024). This evidence concerns the gene MTFP1 and cancer.